|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0008059,
umls-concept:C0013216,
umls-concept:C0023449,
umls-concept:C0205282,
umls-concept:C0205307,
umls-concept:C0205488,
umls-concept:C0220901,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-3-31
|
|
pubmed:abstractText |
Improved cure rates for children with acute lymphoblastic leukemia (ALL) have resulted from better relapse prediction, using clinical and laboratory features at diagnosis, and more intensive therapy in high-risk patients. More recently, measurements of the variation in the response of malignant lymphoblasts to chemotherapy in vivo have further improved relapse prediction. It is unknown whether the variation in the response of nonmalignant hematologic cells after chemotherapy correlates with the response of lymphoblasts or risk of relapse.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2264-71
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15800317-Adolescent,
pubmed-meshheading:15800317-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15800317-Child,
pubmed-meshheading:15800317-Child, Preschool,
pubmed-meshheading:15800317-Cohort Studies,
pubmed-meshheading:15800317-Female,
pubmed-meshheading:15800317-Humans,
pubmed-meshheading:15800317-Infant,
pubmed-meshheading:15800317-Male,
pubmed-meshheading:15800317-Multivariate Analysis,
pubmed-meshheading:15800317-Neoplasm, Residual,
pubmed-meshheading:15800317-Neutropenia,
pubmed-meshheading:15800317-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:15800317-Predictive Value of Tests,
pubmed-meshheading:15800317-Prognosis,
pubmed-meshheading:15800317-Recurrence,
pubmed-meshheading:15800317-Retrospective Studies,
pubmed-meshheading:15800317-Risk Factors,
pubmed-meshheading:15800317-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia.
|
|
pubmed:affiliation |
Centre for Children's Cancer and Blood Disorders, Sydney Children's Hospital, High St, Randwick, Sydney, NSW 2031, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
